Copyright
©The Author(s) 2021.
World J Stem Cells. Sep 26, 2021; 13(9): 1248-1277
Published online Sep 26, 2021. doi: 10.4252/wjsc.v13.i9.1248
Published online Sep 26, 2021. doi: 10.4252/wjsc.v13.i9.1248
Animal model | Scaffold used | ADSCs per implant | Time frame | Defect healing outcomes | Ref. |
-Beagle Dogs; -Unilateral radial segmental defect-10 mm | β-TCP/poly l-lactide-co-glycolide-co-ε-caprolactone composite scaffold | 1 × 106 canine ADSCs | 20 wk | 33.90 ± 4.31 | Kang et al[56] |
-Wistar albino rats; -Middle zygomatic arch defect; -3 mm wide | No scaffold | Rat inguinal fat pad derived SVF | 20 wk | The average new bone growth in the experimental group was 1.1 mm, significantly higher than control | Toplu et al[57] |
Group 1: Pre-differentiated ADSCs | |||||
-New Zealand white rabbits; -Mid-diaphysis of left ulna; -20 mm long | Porous polylactic glycolic acid scaffold | 1 × 106 rabbit SVF cells | 8 wk | Approximately 55% | Kim et al[58] |
-Beagle dogs; -Parietal bone; -20 mm × 20 mm full-thickness defect | Coral scaffold | 60 × 106 of canine ADSCs | 24 wk | 84.19 ± 6.45 | Cui et al[59] |
-Lewis rats; -Calvarial defect -8 mm wide | Polylactic scaffold | 0.1 × 106 rat ADSCs | 8 wk | Coculture of endothelial- and osteoblast-induced ADSC showed no significant improvement over undifferentiated cells | Shah et al[60] |
-Lewis rats; -Calvarial defect; -8 mm wide | Poly (D,L-Lactide) scaffold | 0.1 × 106 rat ADSCs | 8 wk | Osteogenic-induced ADSC generated 0.91 ± 0.65 mm3 new bone, significantly higher than endothelial-induced ADSC | Sahar et al[61] |
Group 2: FGF, VEGF, PDGF, and ADSCs | |||||
-Osterix‐mCherry reporter mice; -Closed transverse diaphysis fractures of the right femur | No scaffold | 0.3 × 106 wild-type mice ADSCs | 35 d | The experimental group induced significantly larger mineralized surface and bone callus compared to cell-free and non-transduced controls. | Zhang et al[62] |
-Balb/c nude mice; -Parietal bone defect; -4 mm wide | Whitlockite‐reinforced gelatin/heparin cryogels | 1 × 106 human ADSCs | 8 wk | > 16% | Kim et al[63] |
-CD1 nude mice; -Parietal bone defect; -4 mm wide | Coral scaffold | 1.5 × 106 human ADSCs | 8 wk | 95.40% | Behr et al[64] |
-Sprague Dawley rats; -Distal femoral cancellous bone -3.5 mm wide and 5 mm deep defect | Trimodal mesoporous bioactive glass scaffold | 20 × 106 cell/mL until saturation; rat ADSCs | 8 wk | 14.25 ± 3.57 | Du et al[65] |
-Nu/Nu J mice; -Parietal bone; -4 mm wide | Polycaprolactone - fibrin scaffold containing heparin-conjugated decellularized bone | 0.2 × 106 human ADSCs | 12 wk | The experimental group induced a significantly larger new bone volume compared to the control without PDGF | Rindone et al[66] |
Group 3: BMP and ADSCs | |||||
-Sprague Dawley rats; -Full-thickness parietal bone defect -5 mm wide | Polylactic glycolic acid scaffold | 0.0025 × 106 human ADSCs | 8 wk | 33.3 ± 29.0 | Park et al[67] |
-Chinese white rabbits; -Full-thickness calvarial defects; -8 mm | Fibrin gel matrix | 3 × 106 rabbit ADSCs | 12 wk | Approximately 48 | Lin et al[68] |
-Japanese white rabbits; -Segmental radial defect; -15 mm | Nano-hydroxyapatite/recombinant human-like collagen/poly (lactic acid) scaffold | 2 × 106 cells/ml; rabbit ADSCs | 12 wk | 97.25 ± 2.06 | Hao et al[69] |
-Taiwan Lee-Sung minipigs; -Mid-shaft left femur defect; -30 mm long | Apatite coated poly (L-lactide-co-glycolide) scaffolds | 100 × 106 cells/animal; minipig ADSCs | 12 wk | Experimental group’s new bone formation showed equivalent density and volume compared to native bone and is significantly better than non-transduced control | Lin et al[70] |
-CD-1 nude mice; -Full-thickness parietal bone defect -3 mm wide | Porous poly(lactic-co- glycolic acid) scaffold | 3 × 106 cells/mL; ADSC from C57BL/6 mouse | 6 wk | 77% | Fan et al[71] |
-Nude mice; -Parietal bone defect; -4 mm wide | Polylactic glycolic acid scaffold | 5 × 105 human ADSCs | 12 wk | 83% | Li et al[72] |
-Nude mice; -Subcutaneous implantation | Porous poly(lactic-co- glycolic acid) scaffold | 0.01 × 106 rat ADSCs | 4 wk | Transduced ADSC construct induced more bone and vessel formation compared to cell-free and non-transduced control | Weimin et al[73] |
-CD‐1 nude mice; -Right parietal bone defect; -4 mm wide | Polylactic glycolic acid scaffold | 0.15 × 106 human ADSCs | 6 wk | Up to 100% | Levi et al[74] |
-Athymic nude rat; -Mandible defect; -5 × 5 mm | Chitosan/chondroitin sulfate scaffold | 0.25 × 106 ADSCs from C57BL/6 mouse | 8 wk | Approximately 43% | Fan et al[75] |
Group 4: Genetically manipulated ADSCs | |||||
-BALB/c nude mice; -Subcutaneous implantation | β-tricalcium phosphate scaffold | 2 × 106 human ADSCs | 8 wk | Approximately 30% | Wang et al[76] |
-Sprague Dawley rats; -Calvarial defect; -8 mm wide and 1 mm thick | Poly (sebacoyl diglyceride) scaffold | Rat ADSCs | 8 wk | 50.53 ± 4.45 | Xie et al[77] |
Group 5: Engineered scaffolds and ADSCs | |||||
-C57BL6/J mice; -Mid femur defect; -2 mm | Strontium-substituted hydroxyapatite poly (γ-benzyl-l-glutamate) scaffold | 5 × 106 C57BL6/J mice ADSCs | 8 wk | Approximately 38% | Gao et al[78] |
-Sprague Dawley rats; -Full-thickness femur defect; -4 mm wide | NaB/polylactic glycolic acid scaffold | 1 × 106 rat ADSCs | 4 wk | ADSC-seeded poly lactic glycolic acid scaffold with 0.05% NaB induced the highest bone density, compared to cell-free control and other concentration of NaB | Doğan et al[79] |
-Balb/c nude mice; -Cranium defect; -4 mm wide | SiRNA lipidoid nanoparticle immobilized on polydopamine coated PLGA scaffold | 1.0 × 106 human ADSCs | 8 wk | Approximately 75% | Shin et al[80] |
-Sprague Dawley rats; -Calvarial defect; -5 mm wide | Collagen-resveratrol scaffold | 0.05 × 106 human ADSCs | 2 wk | Undifferentiated ADSC-seeded construct exhibited better osteogenesis compared to controls and osteoinduced ADSC seeded scaffold | Wang et al[81] |
-Athymic nu/nu mice; -Subcutaneous implantation | Alginate microspheres | 0.5 × 106 rabbit ADSC | 12 wk | Approximately 41% | Man et al[82] |
Group 6: Manipulation of recipient host and ADSCs | |||||
-Sprague-Dawley rats; -Calvarial defect; -7 mm wide | Polylactic glycolic acid scaffold | 1 × 106 human ADSCs | 12 wk | Approximately 60% | Wang et al[83] |
-C57 black/DBA mice; -Supracondylar right femur defect -0.9 mm wide | Hydrogel | 0.3 × 106 mice ADSC | 8 wk | Approximately 50% | Deng et al[84] |
-Osteoporotic Sprague-Dawley female rats; -Distal epiphysis left femur defect; -3 mm wide | Gelatin | 2 × 106 rat ADSCs | 5 wk | Approximately 23% | Li et al[85] |
Group 7: Allogeneic ADSCs | |||||
-New Zealand white rabbits; -Ulna defect; -15 mm | Demineralized bone matrix | 60 × 106 rabbit ADSCs | 12 wk | Both allogeneic and autologous ADSC seeded construct induced almost complete defect repair while cell-free control remained unrepaired | Gu et al[86] |
-Sprague Dawley rats; -Ulna defect; -8 mm long | Demineralized bone matrix | 60 × 106 rat ADSCs | 24 wk | Radiographs and histology confirmed superior bone healing in the experimental group compared to cell-free control | Wen et al[87] |
-Beagle Dogs; -Parietal bone defect; -20 × 20 mm | Coral scaffold | 60 × 106 of canine ADSC | 24 wk | Approximately 70% | Liu et al[88] |
-Wistar rats; -Left radius defect; -4 mm long | Heterogeneous deproteinized bone | 0.1 × 106 rat ADSCs | 8 wk | Radiographs and histology confirmed improved healing in osteoinduced ADSC/scaffold group compared to undifferentiated ADSC, cell-free, and blank controls | Liu et al[89] |
Group 8: Non-manipulated or unaltered ADSCs | |||||
Decellularized matrices | |||||
-CD1 nude mice; -Distal femur defect -3 mm | Human cancellous bone scaffold | 0.5 × 106 human ADSCs | 8 wk | hADSCs-seeded scaffold induced significantly superior defect healing compared to cell-free scaffold | Wagner et al[90] |
-C57BL/6 mice; -Calvarial defect; -4 mm wide | Extracellular matrix deposited on porcine small intestinal submucosa | 0.0025 × 106 of human ADSCs | 4 wk | 21.77 ± 6.99 | Zhang et al[91] |
-Institute of Cancer Research mice; -Full-thickness parietal defect; -4 mm wide | Decellularized tendon | 1.0 × 106 human ADSCs | 8 wk | 86% | Ko et al[92] |
-Sprague Dawley rats; -Two-wall periodontal intrabony defect; -2.6 × 2.0 × 2.0 mm | Amniotic membrane | 0.3 × 106 human ADSCs | 3 wk | ADSC-seeded scaffold resulted in a significantly smaller defect size than the control | Wu et al[93] |
Ceramics | |||||
-Sheep; -Tibia; -3.2 cm long defect | Hydroxyapatite-based particle in a semi-solid milieu | 56 × 106 human ADSCs | 12 wk | The experimental group showed bridging and significantly better healing compared to control | Ben-David et al[94] |
-New Zealand White rabbits; -Full-thickness proximal medial tibia defect; -8 mm wide | Hydroxyapatite | 0.2 × 106 rabbit ADSCs | 8 wk | The new bone area was equivalent between seeded and unseeded scaffold; however, ADSC seeded construct represented preferable histological characteristics | Arrigoni et al[95] |
-New Zealand White rabbits; -Full-thickness proximal medial tibia; -8 mm in diameter | Hydroxyapatite | 1.5 × 106 rabbit ADSCs | 8 wk | ADSC-seeded scaffold exhibited better scaffold resorption than cell-free scaffold and superior histological characteristics compared to all controls | De Girolamo et al[96] |
-Fisher 344 rats; -Calvarial defect; -5 mm wide | Hydroxyapatite | 0.4 × 105 rat ADSCs | 8 wk | 16.88 ± 1.52 | Xia et al[97] |
-T and B cell-deficient NOD SCID mice; -Subcutaneous implantation | Type I collagen (30%) and magnesium-enriched hydroxyapatite | 1 × 106 human ADSCs | 8 wk | hADSC-seeded presented improved osteogenesis and angiogenesis compared to cell-free scaffold control | Calabrese et al[98] |
-Miniature Pigs; -Mandibular defect -3 cm × 1 cm × 2 cm | Tri-calcium phosphate- poly (D,L-lactide-co-glycolide) scaffolds | 5 × 106 porcine ADSCs | 12 wk | 34.8 ± 4.80 | Probst et al[99] |
Bioactive glass | |||||
-Wistar rats; -Full-thickness calvarial defect; -8 mm wide | Bioactive glass | 0.5 × 106 rat ADSCs | 12 wk | ADSC-seeded scaffold group exhibited significantly more bone repair and higher bone density compared to blank control. ADSC construct’s result was equivalent to that of autologous bone graft | Saçak et al[100] |
-Sprague Dawley rats; -Parietal bone defect; -8 mm wide | Icariin doped bioactive glass | 0.5 × 106 rat ADSCs | 12 wk | The experimental group saw the complete repair of the defect while all controls showed various degrees of incomplete healing; repair in the experimental group is characterized by mature bone and complete scaffold resorption | Jing et al[101] |
Polymers | |||||
-Wistar rats; -Calvarial defect; -5 mm wide | Polycaprolactone scaffold | 0.05 × 106 human ADSCs | 8 wk | Both undifferentiated and osteo-induced ADSC-seeded scaffold resulted in preferable histological features and higher expression of osteogenesis and angiogenesis markers | Caetano et al[102] |
Platelet-rich plasma as carrier material | |||||
-Beagle dogs; -Tibial defects; -10 mm wide | Activated platelet-rich plasma | 1.0 × 106 human ADSCs | 6 wk | 68.97 ± 0.91 | Cruz et al[103] |
-F344 rat; -Calvarial defect; -5 mm wide | Activated platelet-rich plasma | 0.2 × 106 rat ADSCs | 8 wk | 95.60 | Tajima et al[104] |
Hybrid materials | |||||
-New Zealand white rabbits; -Calvarial defect; -10 mm wide | Hyaluronic acid-g-chitosan-g-poly (N-isopropylacrylamide) embedded with biphasic calcium phosphate microparticles and PRP | 0.1 × 106 rabbit ADSCs | 16 wk | The experimental group induced obvious significant bone formation and defect bridging. Cell-free scaffold control showed negligible defect repair | Liao et al[105] |
-Sprague Dawley rats; -Parietal defect; -5 mm wide | Multi-layered stacking of electrospun polycaprolactone/gelatin membranes | 0.006 × 106 rat ADSCs | 12 wk | Up to 90% | Wan et al[106] |
-Balb/c nude mice; -Calvarial defect; -4 mm wide | 1H,1H,2H,2H-per- fluorodecyl acrylate (97%) and glycidyl methacrylate coated paper scaffold | 1.0 × 106 cells/paper human ADSCs | 8 wk | 92% | Park et al[107] |
- Citation: Le Q, Madhu V, Hart JM, Farber CR, Zunder ER, Dighe AS, Cui Q. Current evidence on potential of adipose derived stem cells to enhance bone regeneration and future projection. World J Stem Cells 2021; 13(9): 1248-1277
- URL: https://www.wjgnet.com/1948-0210/full/v13/i9/1248.htm
- DOI: https://dx.doi.org/10.4252/wjsc.v13.i9.1248